These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8591378)

  • 1. How to collect, check, and analyze data from clinical trials and be proud of it!
    Cauquil J; Laquais B; Riviere L
    Medinfo; 1995; 8 Pt 2():1095-6. PubMed ID: 8591378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etrank: a ranking procedure for handling missing data in clinical trials: application to venlafaxine extended-release depression clinical trial.
    Entsuah R
    J Biopharm Stat; 1996 Nov; 6(4):457-75. PubMed ID: 8969980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new class of self-designing clinical trials.
    Hartung J
    Stud Health Technol Inform; 2000; 77():310-4. PubMed ID: 11187563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [VIII: Statistics in medical publications: check lists for authors].
    Krummenauer F
    Klin Monbl Augenheilkd; 2003 May; 220(5):362-5. PubMed ID: 12766827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical investigations: innovative management of data. Electronic Data Capture: IOStudy Office].
    Marschner N
    Zentralbl Gynakol; 2001 Aug; 123(8):441-3. PubMed ID: 11562806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDA draft guidance on adaptive design clinical trials: Pfizer's perspective.
    Chuang-Stein C; Beltangady M
    J Biopharm Stat; 2010 Nov; 20(6):1143-9. PubMed ID: 21058110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innovative approaches for designing and analyzing adaptive dose-ranging trials.
    Bornkamp B; Bretz F; Dmitrienko A; Enas G; Gaydos B; Hsu CH; König F; Krams M; Liu Q; Neuenschwander B; Parke T; Pinheiro J; Roy A; Sax R; Shen F
    J Biopharm Stat; 2007; 17(6):965-95. PubMed ID: 18027208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calculation of tolerance limits and sample size determination for clinical trials with dichotomous outcomes.
    Zaslavsky BG
    J Biopharm Stat; 2007; 17(3):481-91. PubMed ID: 17479395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discussion of the paper "Adaptive dose-ranging designs".
    Burman CF
    J Biopharm Stat; 2007; 17(6):1005-11; discussion 1029-32. PubMed ID: 18027210
    [No Abstract]   [Full Text] [Related]  

  • 10. [DNAStat, version 1.0--a software package for processing a genetic profile database and for biostatistical calculations].
    Berent J
    Arch Med Sadowej Kryminol; 2006; 56(1):15-8. PubMed ID: 16708610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of methods for central statistical monitoring in clinical trials.
    Kirkwood AA; Cox T; Hackshaw A
    Clin Trials; 2013 Oct; 10(5):783-806. PubMed ID: 24130202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some extensions to a new approach for interim analysis in clinical trials.
    Falissard B; Lellouch J
    Stat Med; 1991 Jun; 10(6):949-55; discussion 956-7. PubMed ID: 1876784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discussion of the "White Paper of the PhRMA Working Group on adaptive dose-ranging designs".
    Grieve AP
    J Biopharm Stat; 2007; 17(6):997-1004; discussion 1029-32. PubMed ID: 18027209
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of the statistical power for multiple tests: a case study.
    Yeo A; Qu Y
    Pharm Stat; 2009; 8(1):5-11. PubMed ID: 18381588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-level models for repeated measurement data: application to quality of life data in clinical trials.
    Beacon HJ; Thompson SG
    Stat Med; 1996 Dec; 15(24):2717-32. PubMed ID: 8981682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A model to control data flow in multicenter clinical trials.
    Pampallona S
    Methods Inf Med; 1995 Jun; 34(3):283-8. PubMed ID: 7666807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the utility of the Dirichlet distribution for meta-analysis of clinical studies.
    Sankoh AJ; Al-Osh M; Huque MF
    J Biopharm Stat; 1999 May; 9(2):289-306. PubMed ID: 10379695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of an integrated software program to analyze statistically the results of complex investigations in space biology and medicine].
    Pravetskiĭ NF; Nosovskiĭ AM; Kholin SF; Ovchinnikov VV
    Aviakosm Ekolog Med; 1992; 26(2):11-5. PubMed ID: 1301092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the spending function method and the Christmas tree correction for group sequential trials.
    Stallard N; Facey KM
    J Biopharm Stat; 1996 Jul; 6(3):361-73. PubMed ID: 8854238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PAT: an intelligent authoring tool for facilitating clinical trial design.
    Tagaris A; Andronikou V; Karanastasis E; Chondrogiannis E; Tsirmpas C; Varvarigou T; Koutsouris D
    Stud Health Technol Inform; 2014; 205():970-4. PubMed ID: 25160332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.